CancerCare (@CancerCare) header
CancerCare (@CancerCare) profile picture

CancerCare is a national nonprofit organization that provides free emotional, practical and financial support to anyone affected by cancer. 800-813-HOPE

New York, New York
Joined April 2009
Photo by CancerCare (@CancerCare)Photo by CancerCare (@CancerCare)Photo by CancerCare (@CancerCare)Photo by CancerCare (@CancerCare)Photo by CancerCare (@CancerCare)Photo by CancerCare (@CancerCare)Photo by CancerCare (@CancerCare)Photo by CancerCare (@CancerCare)Photo by CancerCare (@CancerCare)Photo by CancerCare (@CancerCare)
Last year, @CancerCare provided 150,508 services to people diagnosed with cancer, caregivers and bereaved individuals. Our emotional, practical and financial support programs continued to offer help and hope to anyone affected by cancer. Learn more at cancercare.org.
2
1
1
6
1,019
Today, FDA approved a combination treatment for adults with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative, estrogen receptor 1 (ESR1)-mutated locally advanced or metastatic breast cancer. fda.gov/drugs/cancer-approva…
2
4
1
9
2,790
Today, we have approved a new treatment regimen for adults with muscle-invasive bladder cancer who are unable to receive or have declined cisplatin-based chemotherapy. fda.gov/drugs/cancer-approva…
2
17
3,733
What are biomarkers and what can biomarker testing mean for your cancer and your care? Learn more by visiting cancercare.org/biomarkers #CancerBiomarkers #CancerBiomarkerDay
1
76
Today, FDA approved a treatment for symptomatic tenosynovial giant cell tumor for which surgical resection may cause worsening functional limitation or severe morbidity.  fda.gov/drugs/cancer-approva…
1
9
1
15
3,438
CancerCare retweeted
Join us this Sunday, 11/15, at CancerCare’s Annual Walk for Hope! For more than 80 years, @CancerCare has provided free emotional and practical support for people with cancer, caregivers, loved ones and the bereaved.
1
2
1
4
227
Today, FDA approved a treatment for adult patients with recurrent or metastatic head and neck squamous cell cancer whose disease has progressed on or after platinum-based chemotherapy and immunotherapy. This is an aggressive, life-threatening disease for which there is a high unmet need for effective therapies. fda.gov/news-events/press-an…
5
9
3
39
6,698
CancerCare retweeted
Explore non-squamous non-small cell lung cancer #ClinicalStudy options through myTRIAList. Our study finder features plain-language study overview videos, including the TeliMET #NSCLC-04 study, that help make study information more accessible. Learn more: bit.ly/4A7BNfO
1
1
46
We brought the Long Island cancer community together for a free, fall-inspired afternoon of pumpkin painting, creativity, and connection. Explore more of our community programs: loom.ly/eViNF0w
1
104
Would you consider using AI to help find a cancer clinical trial? This month, CancerCare wants to hear your thoughts and experiences with AI tools to find #clinicaltrials. Share your perspective through our Question of the Month poll: cancercare.org/question
78
CancerCare retweeted
A @PioneerPolicy and @CancerCare study found that 340B hospitals spend an average of just 2.16% of operating expenses on charity care. Non-340B hospitals spend 2.82%. Why are hospitals receiving billions in discounts to help vulnerable patients providing less charity care? forbes.com/sites/sallypipes/…
3
1
6
314
CancerCare retweeted
Understanding #ClinicalTrials can feel overwhelming. Noelle Cloven, MD, from Texas Oncology, shares insights in the RAINFOL-03 study video on myTRIAList. Explore possible clinical trial options and learn more here: bit.ly/4ssM3wu #EndometrialCancer #CancerResearch
1
1
55
NEWS: Today, FDA approved a new treatment for metastatic androgen pathway modulation-naïve or -sensitive prostate cancer. fda.gov/drugs/resources-info…
1
13
1
23
7,247
New in @Forbes: Sally Pipes cites research from Pioneer and @CancerCare finding 340B hospitals spent an average of 2.16% of operating expenses on charity care vs. 2.82% for non-340B hospitals. Read it here: bit.ly/4sdBqgK 🔒
3
2
6,754
#340B reform must be a priority to improve access to healthcare for cancer patients, according to Kim Czubaruk of @CancerCare in a new opinion. Congress should take action to improve 340B transparency and accountability so patients benefit. Read more in @RealClearHealth: realclearhealth.com/articles…
2
5
187
FDA has granted accelerated approval of an immunotherapy for adults with previously untreated stage II or III locally advanced rectal cancer whose tumors are dMMR or MSI-H. In a phase 2 study, almost three-fourths of patients did not need surgery, radiotherapy, or chemotherapy after a median follow-up of more than 2 years. For eligible patients, treatment may help avoid chemotherapy, radiation and surgery and their lasting effects. This is the 11th approval under the Commissioner’s National Priority Voucher pilot program.
12
54
6
223
42,423
CancerCare retweeted
📋 New post-transplant GvHD symptom tracker Record your symptoms and track changes over time with our downloadable tracker. 💻 Complete digitally 🖨️ Or print and fill it in by hand 👩‍⚕️ Share with your healthcare team to help identify patterns or changes. 🔗 Download the tracker here: bit.ly/4jfm4pG #GvHD Independently supported by Therakos. Funders are allowed no influence.
3
1
179
Big news for bladder cancer patients! FDA just expanded approval of Anktiva with BCG for adults with BCG-unresponsive, high-grade papillary-only NMIBC — the first treatment approved for this group. This is a first, and that matters. Evidence from a closely related form of bladder cancer supported the approval. fda.gov/drugs/resources-info…
39
99
31
430
53,964